|
Cold Spring Harbor, NY and Cambridge, Massachusetts USA, June
29, 2007. CompuCyte Corporation and Cold Spring Harbor
Laboratory (CSHL) today announced the establishment of the first
U.S.-based Regional Quantitative Imaging Cytometry Center of
Excellence. Located at CSHL and jointly run by the two
organizations, the Center will provide educational and training
resources for quantitative imaging cytometry (QIC) based on
CompuCyte’s laser scanning technology (LSC).“Quantitative
Imaging Cytometry is an emerging area with extraordinary
potential for cancer research,” stated Nicholas Tonks, Ph.D.,
FRS, Director of Shared Resources for the CSHL Cancer Center.
“As an NCI-designated Cancer Center, CSHL strives to provide its
researchers with the latest technologies to facilitate their
work. CSHL’s partnership with CompuCyte gives our scientists
full advantage of the power of this technology and will allow
them to develop new applications for its use.” Under the
agreement, which extends and expands an existing relationship
between the two organizations, CSHL and CompuCyte will sponsor
an annual symposium and several training programs throughout the
year, focusing on new QIC techniques for researchers using LSC
systems in cell and tissue-based research. The Center will be
guided by an advisory committee of renowned cytometry experts:
·
Zbigniew
Darzynkiewicz, M.D., Ph.D., Director, Brander Cancer Research
Institute, New York Medical College, Valhalla, NY
· William
Geddie, M.D., Department of Pathology, University Health Network
and Assistant Professor, University of Toronto
· James
Jacobberger, Ph.D., Professor of Oncology, Associate Director
for Shared Resources, Director: Cell Analysis Core, Case
Comprehensive Cancer Center, Cleveland, OH
· Gloria
Juan, Ph.D., Sr. Scientist, Amgen, Thousand Oaks, CA
· William
Telford, Ph.D., Director, Core Flow Cytometry Resource, National
Cancer Institute of the National Institutes of Health, Bethesda,
MD
“CompuCyte’s laser
scanning cytometry technology is the first technology on the
market to combine quantitative measurement of cellular
constituents with comprehensive imaging at various degrees of
resolution, in a single powerful instrument,” said Dr. Elena
Holden, CompuCyte’s President and CEO. “Our agreement with CSHL
fills a critical need for advanced training and application
development in the emerging discipline of quantitative imaging
cytometry. CSHL’s unsurpassed reputation for life science
research and education makes it a natural home for this Center.”
“Progress in cell biology is being driven by development of new
analytical tools and methods,” explained Zbigniew Darzynkiewicz,
Director of the Brander Cancer Center in Valhalla, NY.
“Cytometry instrumentation, including laser scanning cytometry,
has immensely expanded analytical capabilities designed to probe
individual cells and will be invaluable for further progress in
cell research.”
CSHL is a private, non-profit research and education
institution dedicated to exploring molecular biology and
genetics in order to advance the understanding and ability to
diagnose and treat cancers, neurological diseases, and other
causes of human suffering. For more information about CSHL
visit
www.cshl.edu
CompuCyte Corporation, a private company headquartered in
Cambridge, Massachusetts, is a leader in the development of
cellular analysis instrumentation for life science research,
drug safety, toxicology studies and clinical trials. The
company’s iCyte®, iCys®, and iColor™
cytometers enable quantitative cytometric image analysis of
cellular and tissue specimens. For more information about the
technology visit
www.compucyte.com. |
